• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PI3K/AKT/PTEN信号通路作为药物治疗靶点的作用

Roles of PI3K/AKT/PTEN Pathway as a Target for Pharmaceutical Therapy.

作者信息

Matsuda Satoru, Nakanishi Atsuko, Wada Yoko, Kitagishi Yasuko

机构信息

Department of Food Science and Nutrition, Nara Women's University, Kita-Uoya Nishimachi, Nara 630-8506, Japan.

出版信息

Open Med Chem J. 2013 Oct 31;7:23-9. doi: 10.2174/1874104501307010023. eCollection 2013.

DOI:10.2174/1874104501307010023
PMID:24222802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3821079/
Abstract

Multiple enzymes participate in the phosphorylation of a group of phosphoinositide lipids. Because of their important role in signal transduction, the dysregulated metabolism of phosphoinositides represents a key step in many disease settings. Loss of their function has been demonstrated to occur as an early event a wide variety of carcinogenesis and has therefore been suggested as a biomarker for the premalignant disease. In addition, genetic alterations at multiple nodes in the pathway have been implicated in several other diseases. Accordingly, given this pervasive involvement in many diseases, the development of molecules that modulates this pathway has been initiated in studies. They have been the focus of extensive research and drug discovery activities. A better understanding of the molecular connections could uncover new targets for drug development.

摘要

多种酶参与一组磷酸肌醇脂质的磷酸化过程。由于它们在信号转导中发挥重要作用,磷酸肌醇代谢失调是许多疾病发生过程中的关键步骤。已证明其功能丧失是多种癌症发生过程中的早期事件,因此被认为是癌前疾病的生物标志物。此外,该信号通路多个节点的基因改变与其他几种疾病有关。因此,鉴于其在多种疾病中的广泛参与,目前已开始研究开发调节该信号通路的分子。它们一直是广泛研究和药物研发活动的重点。对分子间联系的深入了解可能会揭示药物开发的新靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fdd/3821079/bb0994356878/TOMCJ-7-23_F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fdd/3821079/a6dceb560d71/TOMCJ-7-23_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fdd/3821079/1881f76f85c5/TOMCJ-7-23_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fdd/3821079/497909c82113/TOMCJ-7-23_F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fdd/3821079/bb0994356878/TOMCJ-7-23_F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fdd/3821079/a6dceb560d71/TOMCJ-7-23_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fdd/3821079/1881f76f85c5/TOMCJ-7-23_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fdd/3821079/497909c82113/TOMCJ-7-23_F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fdd/3821079/bb0994356878/TOMCJ-7-23_F4.jpg

相似文献

1
Roles of PI3K/AKT/PTEN Pathway as a Target for Pharmaceutical Therapy.PI3K/AKT/PTEN信号通路作为药物治疗靶点的作用
Open Med Chem J. 2013 Oct 31;7:23-9. doi: 10.2174/1874104501307010023. eCollection 2013.
2
Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway.靶向翻译机制改善白血病治疗:PI3K/PTEN/Akt/mTOR 通路的作用。
Leukemia. 2011 Jul;25(7):1064-79. doi: 10.1038/leu.2011.46. Epub 2011 Mar 25.
3
Pharmacogenomic profiling of the PI3K/PTEN-AKT-mTOR pathway in common human tumors.常见人类肿瘤中PI3K/PTEN-AKT-mTOR通路的药物基因组学分析
Int J Oncol. 2004 Apr;24(4):893-900.
4
Effective PI3K modulators for improved therapy against malignant tumors and for neuroprotection of brain damage after tumor therapy (Review).用于改善恶性肿瘤治疗及肿瘤治疗后脑损伤神经保护的有效PI3K调节剂(综述)
Int J Oncol. 2016 Nov;49(5):1785-1790. doi: 10.3892/ijo.2016.3710. Epub 2016 Sep 27.
5
PI3K/AKT/PTEN pathway as a target for Crohn's disease therapy (Review).PI3K/AKT/PTEN信号通路作为克罗恩病治疗靶点(综述)
Int J Mol Med. 2015 Jan;35(1):10-6. doi: 10.3892/ijmm.2014.1981. Epub 2014 Oct 27.
6
GDC-0980 is a novel class I PI3K/mTOR kinase inhibitor with robust activity in cancer models driven by the PI3K pathway.GDC-0980 是一种新型的 I 类 PI3K/mTOR 激酶抑制剂,在由 PI3K 通路驱动的癌症模型中具有强大的活性。
Mol Cancer Ther. 2011 Dec;10(12):2426-36. doi: 10.1158/1535-7163.MCT-11-0446. Epub 2011 Oct 13.
7
Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway.PI3K/AKT/mTOR 通路中癌症治疗的分子靶点。
Pharmacol Ther. 2014 May;142(2):164-75. doi: 10.1016/j.pharmthera.2013.12.004. Epub 2013 Dec 9.
8
Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy.唾液腺癌中频繁的 PTEN 缺失和差异的 HER2/PI3K 信号通路改变:对靶向治疗的影响。
Cancer. 2018 Sep 15;124(18):3693-3705. doi: 10.1002/cncr.31600. Epub 2018 Oct 5.
9
PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control.PI3K-Akt信号通路调控中的PTEN肿瘤抑制网络
Genes Cancer. 2010 Dec;1(12):1170-7. doi: 10.1177/1947601911407325.
10
Specific gene expression signatures induced by the multiple oncogenic alterations that occur within the PTEN/PI3K/AKT pathway in lung cancer.肺癌中PTEN/PI3K/AKT途径内发生的多种致癌改变所诱导的特定基因表达特征。
PLoS One. 2017 Jun 29;12(6):e0178865. doi: 10.1371/journal.pone.0178865. eCollection 2017.

引用本文的文献

1
Exploring Monogenic, Polygenic, and Epigenetic Models of Common Variable Immunodeficiency.探索常见可变免疫缺陷的单基因、多基因和表观遗传模型。
Hum Mutat. 2025 Apr 15;2025:1725906. doi: 10.1155/humu/1725906. eCollection 2025.
2
Simultaneous suppression of miR-21 and restoration of miR-145 in gastric cancer cells; a promising strategy for inhibition of cell proliferation and migration.同时抑制胃癌细胞中的miR-21并恢复miR-145;一种抑制细胞增殖和迁移的有前景的策略。
Bioimpacts. 2024;14(2):27764. doi: 10.34172/bi.2023.27764. Epub 2023 Aug 27.
3
The Chemopreventive Effects of Chlorogenic Acids, Phenolic Compounds in Coffee, against Inflammation, Cancer, and Neurological Diseases.

本文引用的文献

1
Signal integration by mTORC1 coordinates nutrient input with biosynthetic output.mTORC1 通过信号整合协调营养物质输入与生物合成产出。
Nat Cell Biol. 2013 Jun;15(6):555-64. doi: 10.1038/ncb2763.
2
Comparative effects of PP242 and rapamycin on mTOR signalling and NOTCH signalling in leukemia cells.PP242 和雷帕霉素对白血病细胞中 mTOR 信号和 NOTCH 信号的比较影响。
Anticancer Res. 2013 Mar;33(3):809-13.
3
PI3K/Akt/mTOR pathway inhibitors in the therapy of pancreatic neuroendocrine tumors.PI3K/Akt/mTOR 通路抑制剂在胰腺神经内分泌肿瘤治疗中的应用。
绿原酸的化学预防作用,咖啡中的酚类化合物,可预防炎症、癌症和神经退行性疾病。
Molecules. 2023 Mar 4;28(5):2381. doi: 10.3390/molecules28052381.
4
A molecular insight of inflammatory cascades in rheumatoid arthritis and anti-arthritic potential of phytoconstituents.类风湿关节炎中炎症级联反应的分子见解及植物成分的抗关节炎潜力
Mol Biol Rep. 2022 Mar;49(3):2375-2391. doi: 10.1007/s11033-021-06986-7. Epub 2021 Nov 24.
5
In Silico and In Vivo Studies on the Mechanisms of Chinese Medicine Formula (Gegen Qinlian Decoction) in the Treatment of Ulcerative Colitis.中药方剂(葛根芩连汤)治疗溃疡性结肠炎机制的计算机模拟及体内研究
Front Pharmacol. 2021 Jun 11;12:665102. doi: 10.3389/fphar.2021.665102. eCollection 2021.
6
and Methylation and Somatic Mutations as Precision Medicine Biomarkers for Diagnosis and Prognosis of High-grade Serous Ovarian Cancer.甲基化和体细胞突变作为高级别浆液性卵巢癌诊断和预后的精准医学生物标志物。
Cancer Prev Res (Phila). 2020 Sep;13(9):783-794. doi: 10.1158/1940-6207.CAPR-19-0412. Epub 2020 Jun 24.
7
Primordial follicle activation as new treatment for primary ovarian insufficiency.原始卵泡激活作为原发性卵巢功能不全的新疗法。
Clin Exp Reprod Med. 2019 Jun;46(2):43-49. doi: 10.5653/cerm.2019.46.2.43. Epub 2019 Jun 1.
8
Multi-focal sequencing of a diffuse intrinsic pontine glioma establishes PTEN loss as an early event.弥漫性脑桥内在型胶质瘤的多焦点测序确定PTEN缺失是早期事件。
NPJ Precis Oncol. 2017 Sep 14;1(1):32. doi: 10.1038/s41698-017-0033-y. eCollection 2017.
9
Effect of tibolone pretreatment on kinases and phosphatases that regulate the expression and phosphorylation of Tau in the hippocampus of rats exposed to ozone.替勃龙预处理对暴露于臭氧的大鼠海马中调节Tau蛋白表达和磷酸化的激酶及磷酸酶的影响。
Neural Regen Res. 2018 Mar;13(3):440-448. doi: 10.4103/1673-5374.228726.
10
Thyroid follicular adenomas and carcinomas: molecular profiling provides evidence for a continuous evolution.甲状腺滤泡性腺瘤和癌:分子剖析为连续演变提供了证据。
Oncotarget. 2017 Dec 8;9(12):10343-10359. doi: 10.18632/oncotarget.23130. eCollection 2018 Feb 13.
Cancer Lett. 2013 Jul 10;335(1):1-8. doi: 10.1016/j.canlet.2013.02.016. Epub 2013 Feb 16.
4
Equivalent benefit of rapamycin and a potent mTOR ATP-competitive inhibitor, MLN0128 (INK128), in a mouse model of tuberous sclerosis.雷帕霉素和一种强效的 mTOR ATP 竞争性抑制剂 MLN0128(INK128)在结节性硬化症小鼠模型中的等效疗效。
Mol Cancer Res. 2013 May;11(5):467-73. doi: 10.1158/1541-7786.MCR-12-0605. Epub 2013 Feb 5.
5
Versatile inhibitory effects of the flavonoid-derived PI3K/Akt inhibitor, LY294002, on ATP-binding cassette transporters that characterize stem cells.黄酮类化合物衍生的 PI3K/Akt 抑制剂 LY294002 对表征干细胞的 ATP 结合盒转运蛋白的多功能抑制作用。
Clin Transl Med. 2012 Oct 13;1(1):24. doi: 10.1186/2001-1326-1-24.
6
PI-103 sensitizes acute myeloid leukemia stem cells to daunorubicin-induced cytotoxicity.PI-103 增强急性髓系白血病干细胞对柔红霉素诱导的细胞毒性作用。
Med Oncol. 2013 Mar;30(1):395. doi: 10.1007/s12032-012-0395-5. Epub 2013 Jan 19.
7
Roles of PI3K/AKT/GSK3/mTOR Pathway in Cell Signaling of Mental Illnesses.PI3K/AKT/GSK3/mTOR通路在精神疾病细胞信号传导中的作用
Depress Res Treat. 2012;2012:752563. doi: 10.1155/2012/752563. Epub 2012 Dec 18.
8
Perifosine in renal cell carcinoma.培呋辛在肾细胞癌中的应用。
Expert Opin Investig Drugs. 2013 Feb;22(2):285-91. doi: 10.1517/13543784.2013.754422. Epub 2012 Dec 20.
9
Inhibition of PI3K signaling spurs new therapeutic opportunities in inflammatory/autoimmune diseases and hematological malignancies.PI3K 信号抑制为炎症/自身免疫性疾病和血液系统恶性肿瘤带来新的治疗机会。
Pharmacol Rev. 2012 Oct;64(4):1027-54. doi: 10.1124/pr.110.004051.
10
Diabetes diminishes phosphatidic acid in the retina: a putative mediator for reduced mTOR signaling and increased neuronal cell death.糖尿病会减少视网膜中的磷脂酸:一种可能的促分裂原活化蛋白激酶信号转导减少和神经元细胞死亡增加的介质。
Invest Ophthalmol Vis Sci. 2012 Oct 19;53(11):7257-67. doi: 10.1167/iovs.11-7626.